8th Grand Edition of Healthcare Excellence Awards Virtual Ceremony

The 8th Grand Edition of Healthcare Excellence Awards Virtual Ceremony was held on 5th July 2020 to felicitate achievers of industry under various domains like Healthcare practitioners, physicians, Pharma companies, Medical companies, Hospitals &Research Institutions from all over India. It also offered healthcare service providers the opportunity to learn specific tools and techniques to achieve efficiency through innovation and strategy, in an environment of quality learning and peer networking.

About 8th Grand Edition of CIMS Healthcare Excellence Awards Virtual Ceremony 2020

One of its kind virtual show Healthcare Excellence Awards was conducted by CIMS Medica to recognize excellence in healthcare on 5th July 2020. The show witnessed presence of VIPs & key dignitaries from the industry including Chief Guest Shri D C Sahu, Director MSME – Development Institute, Indore, distinguished Guest of Honor Dr. Sunil Khetarpal, Chief Transformation Officer Rajiv Gandhi Cancer Institute and Research Center, Delhi, Key note speakers Dr. CM Bhagat, President Association of Healthcare Providers of India (AHPI) &  Adv. Shashank Deshpande, Medico-legal Consultant, Mumbai and representing team CIMS Medica was the organizer Dr. Monica Sood Bhatia, Managing Director of CIM Medica (India & Middle-East). The show was hosted by Actor JitenLalwani.

The show started with a panel discussion on “Impact of COVID-19 Pandemic on Healthcare Scenario in India” followed by a product launch of CIMS Telehealth a Telemedicine platform for Doctors and Patients & in the end was the Awards ceremony. The awards felicitated achievers of industry under various domains including individual winners & winning companies like Gluconorm-G (Lupin), Sanity Pharma, Ultra D3 10K-Meyer Vitabiotics, Zermero Advance Handrub (Solace Biotech), Swich (Alkem), Bluestar Laboratories, Lloyd Healthcare Pvt. Ltd., Psychocare Health Pvt. Ltd., Talkmed (NGS Biotech Pvt. Ltd.), Reshake Forte (Shakam Lifesciences), Delwis Healthcare, BrostinSeizz Biocare, Zylig Lifesciences, Beyoung Store (Deccan Healthcare), Telista (Lupin), I Well Pharma, AlkemHospicare, Charan Laboratories, Dr. RamavtarBumb, Mr. Shaji John (Rubi Hall Clinic), Yashoda Group of Hospitals and Ratnaprash (Dabur).

This CIMS virtual event was very well applauded and appreciated by all the participants & industry experts.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

    9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s Govandi

    9,800 psychotropic tablets worth ₹2.53 crore seized in Mumbai’s Govandi

    Story of Bariatric Surgery Joining One Family’s Battle Against Severe Obesity

    Story of Bariatric Surgery Joining One Family’s Battle Against Severe Obesity

    Maharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up Risk

    Maharashtra FDA Cancels Three Cadila Pharma Licences Over Aciloc, Aciloc+ Drug Mix-Up Risk